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Neuroprotective effects of pulsed electromagnetic fields (PEMFs) have been demonstrated both in 
vivo and in vitro. Moreover, preliminary clinical studies have been conducted and suggested PEMFs as 
a possible alternative therapy to treat acute ischemic stroke. In this work, we show that it’s possible 
to build-up a patient semi-specific head model, where the 3D reconstruction of the ischemic lesion of 
the patient under treatment is inserted in the head of the human body model “Duke” (v.1.0, Zurich 
MedTech AG). The semi-specific model will be used in the randomized, placebo-controlled, double-blind 
study currently ongoing. Three patients were modelled and simulated, and results showed that each 
ischemic lesion experiences a magnetic flux density field comparable to the one for which biological 
effects have been attested. Such a kind of dosimetric analysis reveals a reliable tool to assess the 
correlation between levels of exposure and the beneficial effect. Thus, once the on-going double blind 
study is complete it will prove if PEMFs treatment triggers a clinical effect, and we will then be able to 
characterize a dose-response curve with the methodology arranged in this study.
A cerebral stroke is a sudden insult that occurs after complete or partial blood flow interruption to the brain. 
Whether this lack of blood flow is due to a restriction or to a full occlusion of arterial vessels supplying the 
brain, the stroke is said to be ischemic. Ischemic stroke, which accounts for approximately 80% of all strokes, 
is the third cause of death worldwide and the main cause of chronic, severe adult disabilities1. The ischemic 
lesion consists of a central core, with severely compromise cerebral blood flow (CBF) which leads to immediate 
neuronal death. The core is surrounded by a rim of ischemic tissue characterized by impaired electrical activ-
ity but preserved cellular metabolism, known as the penumbra. As an opposite to the core, the penumbra is 
reversibly damaged. In this case, tissue salvage may be achieved when re-perfusion is established within a 6- to 
8-hour period2. Even though thrombolysis is nowadays the most widely diffuse therapy to treat strokes, impor-
tant advances made in the understanding of the pathophysiological mechanisms underlying the evolution of the 
ischemic penumbra have brought to light the alternative approach of neuroprotection. Neuroprotection aims to 
antagonize the harmful molecular and cellular events responsible for the ischemic damage, allowing brain cells 
to survive to the reduced CBF and to stabilize penumbra1. Because of this, several studies have suggested the 
hypothesis that electromagnetic fields exposure may be an interesting approach as a noninvasive treatment with 
a low impact on daily life3. In the early 2000s, extremely low frequency magnetic fields have shown to enhance 
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neurite outgrowth4 and to save rat cerebellar granule neurons from apoptosis5. More recently, Urnukhsaikhan 
et al. demonstrated a neuroprotective effect of low frequency-pulsed electromagnetic fields (LF-PEMF) in mice 
after ischemic stroke6. Specifically, the authors showed that LF-PEMF exposure increases resistance to apoptosis 
via activation of the TrkB/Akt/Bad pathway and the upregulation of brain-derived neurotrophic factor (BDNF) 
expression, while decreasing the level of inflammatory mediators, such as Interleukin 1 beta (IL-1β) and Matrix 
metalloproteinase-9 (MMP9). Moreover, LF-PEMF exposure was able to significantly improve mouse behavior 
during the recovery process. Pena-Philippides et al. studied the effects of PEMF exposure on infarct size and 
inflammation following distal middle cerebral artery occlusion (dMCAO) in mice7. This work demonstrated 
that PEMFs reduce the size of the ischemic lesion measured by MRI and modify the profile of pro-inflammatory 
cytokines causing an anti-inflammatory and anti-apoptotic effect. Segal et al. studied a very low intensity, low 
frequency, electromagnetic field treatment (VLIFE) on an in vivo stroke rat model8. Brain MRI imaging showed a 
decrease in perilesional edema and lateral ventricle widening in the treated groups. Treated rats showed recovery 
of sensory-motor functional deficits, as demonstrated by Modified Neurological Severity Score and forelimb 
placement tests. The authors concluded that VLIFE stimulation promotes neuronal plasticity after stroke, thus 
improving clinical recovery. In 2002 Varani and co-workers9 demonstrated that exposures to low frequency and 
low energy pulsed electromagnetic fields (PEMFs) induces the upregulation of A2A adenosine receptors (ARs) in 
human neutrophils with a magnetic flux density in the range of 1–3.5 mT. A subsequent study, conducted on rat 
cerebral cortex and cortical neurons, has also confirmed that the effect of PEMFs exposure is selective for A2A and 
A3 ARs10. These are fundamental achievements, considering that A2A and A3 play a key role in protection against 
ischemic damage10,11. In order to better understand the effect of PEMFs in neuronal cells following hypoxia injury, 
Vincenzi and co-workers12 exposed human neuroblastoma cell line SH-SY5Y and rat pheochromocytoma PC12 
cells, cell lines endowed with long term proliferative capacity in-vitro and widely accepted as good neuron-like 
cell models13,14. Results showed that PEMFs stimulation significantly reduced hypoxia-induced cell death. The 
signal used for the in vitro experiments by the group of Varani9,10,12 is the same that has been used in the study 
conducted in Grant et al. in 199415, where they evaluated potential beneficial effect of PEMFs on rabbit cerebral 
damage. These results showed attenuated cortical edema, when considering magnetic resonance imaging (MRI), 
and in a reduced neuronal damage, assessed with histological examination. Besides, the aforementioned signal 
is also able to produce changes in the excitability of the human cerebral cortex16. Moving to human studies, an 
open-label, one-arm, dose-escalation, exploratory study17 was carried out in order to evaluate the safety and tol-
erability of PEMFs in patients with acute ischemic stroke. The study consisted of a 5-day intervention phase and 
a 12-month follow-up phase. Within 48 hours from the stroke onset, the six enrolled patients underwent PEMFs 
treatment daily for 5 consecutive days. Clinical follow up lasted 12 months and brain MRI was performed before, 
and at the one month mark after the treatment. According to the protocol, the first group of three patients was 
stimulated for 45 min/day and the second group of three patients for 120 min/day. No adverse events occurred 
during the treatment and clinical conditions improved in all patients. In particular, lesion size was reduced in one 
of the patients stimulated for 45 minutes and in all of those stimulated for 120 minutes.
This study opened the pathway to a new second research avenue: an on-going randomized, placebo-controlled, 
double-blind study (I-NIC)18. This clinical trial foresees approximately 124 patients, still in the recruiting phase, 
and will clarify whether PEMFs represent a novel approach to neuroprotection with the final aim to identify a 
dose-response curve. This is an essential pre-requistite to apply physical agents as PEMFs as a medical treatment 
in an electroceuticals perspective19. The estimation of the electric and magnetic quantities inside the brain tissue 
that are able to elicit an effect is indeed an unavoidable step to an effective and reliable use of the electric or mag-
netic stimulation of the brain20; one of the most adopted approaches is the use of computational dosimetry21–33.
The dosimetric computation can be performed by numerically solving the electromagnetic problem inside 
realistic brain models, stimulated by simplified or realistic sources models. The quantities calculated are the mag-
netic flux density field (B), electric field (E) and current density (J) distributions induced in the brain. Indeed, 
knowledge of B, E, J field distribution is fundamental for evaluating position, level, and extent of the stimulation. 
Due to the generally high wavelength of the stimulating field with respect to the head size, most of these methods 
use quasi–static approximation to determine the distribution of the fields induced in the human brain25–31.
The present paper aims to identify a methodology for a dose-response curve assessment, suitable to be applied 
in a large scale clinical study. In particular, it is preparatory for the computational dosimetry that will be carried 
out on the 124 patients recruited in the multicentric double blind I-NIC study18. Therefore, in this paper, a dosi-
metric study, based on a magneto-quasistatic solution at macroscopic level was performed, using a semi-specific 
head model of the patients. The novelty of semi-specific approach is to represent the ischemic volume of each 
patient inserted in the correct position inside a standard human head model. This leads to a faster and reliable 
procedure suitable for the analysis of a large sample of patients. Moreover, in order to assess a methodology able 
to identify a threshold and a dose-response curve, we proceeded to obtain a post-treatment model of the ischemia 
for each patient, that was accurately placed in the semi-specific head model, to compare pre- and post-treatment 
ischemic volumes. Ratio of the volumes in the head space were correlated to the exposure intensity (B) field in 
order to quantify if, and where, we could observe a significant reduction. Similar calculations have been perfomed 
also for the J field.
Such a methodology is applied here to the reduced sample of the three patients recruited in Capone et al.17 
that underwent magnetic stimulation for 120 minutes (the same treatment duration as the one used in the I-NIC 
study18). Such a pool of data seems to be consistent with the final aim since in both cases, the magnetic source is 
a single monolateral solenoid placed on the patient head, therefore the dosimetric methodology proposed here 
will be applicable for the I-NIC study18.
As shown in Capone et al.17, this source application implied a gradient of B transverse to the head that 
decreases with the distance from the solenoid itself. From a dosimetric point of view, this opened the question on 
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the exposure experimented by the different ischemic regions as a function of distance. This is a crucial point in 
order to be able to identify the minimal exposure threshold to attain the effect.
This study lays the groundwork for a methodology, that once applied to the I-NIC18 patients, will be able to 
identify the stimulation threshold capable of triggering (if any) a neuroprotective effect.
Results
As expected, electromagnetic simulations show that the magnetic flux density field is not altered from the pres-
ence of the head, nor from each of its structures. In Fig. 1 streamline view of B field is shown together with the 
distribution of ||B|| over the surface of the ischemia (zoom in the inset) for each of the three patients. Data is 
shown through a color scale from black to white: intensities above 1 mT are represented as shading from red to 
white, while lower intensities ranges from purple to black. Here the gradient that the field experiences is clearly 
visible and its intensity is inversely proportional to the distance from the stimulating coil. Patient AA has the big-
gest lesion, which is exposed to a B field that varies from 1 mT to 2.2 mT, while those of patient BB and patient CC 
are smaller, so experiencing a more uniform B field. Between the two, being the ischemia of patient BB closer to 
the coil, it ensures an exposure to higher values (1.5 mT to 1.9 mT) with respect to that of patient CC (1 mT to 1.3 
mT). Thus, the field that the lesion is exposed to depends on its dimension and position: the smaller the ischemia, 
the smaller the space variation of B values it experiences; the deeper, the lower is the intensity. In order to obtain 
the most reliable values of the B field and of the current density J induced in each voxel belonging to the ischemic 
volume we reconstructed the time course of the signal following the same approach to the electromagnetic solu-
tion as the one followed in Paffi et al.22, where a total of 150 simulations were performed. Fig. 2 reports the time 
Figure 1. Streamline view of B field along the frontal plane (f-plane in the coil based coordinate, see Methods) 
for the three patients shows direction of the B field inside the head. In green: pre-treatment ischemic volume; 
in cyan: post-treatment ischemic volume. Blue inset shows the spatial gradient of ||B|| which the ischemia is 
exposed to during the treatment.
Figure 2. (a) Time course of ||B|| field for all patients in the voxel of the pre-treatment ischemic volume that 
experiences the lowest B. All the three patients undergo to at least 1 mT; (b) Time course of induced J for all 
patients in the voxel of the pre-treatment ischemic volume that experiences the highest value of J.
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course of ||B|| in the voxel that experiences the lowest ||B|| (Fig. 2a), and the time course of J inside the voxel that 
experiences the highest J (Fig. 2b). The most important observation is that all the three lesions are exposed to a 
field greater than or equal to 1 mT, which is the threshold of attested biological effects13,14. Patient AA and patient 
CC experience the same minimum value. This is because they both expand towards deeper regions of the brain. 
Regarding the time course of ||B|| in the voxel that experiences the maximum ||B|| field (Supplementary Fig. S1), 
the peak is slightly above 2 mT for patient AA, slightly below 2 mT for patient BB and slightly above 1 mT for 
patient CC. For the time course of J (Fig. 2b), patient AA is characterized by highest values due to the combined 
effect of the dimensions of the ischemia and the highest values of ||B|| (just above 2 mT). As a matter of fact, we 
expect a greater induction in a wider surface, according to Faraday’s law. For patient BB and patient CC, the dif-
ferent cross-sections of the two lesions force the two current densities to have similar values, despite experiencing 
different B field intensities. The absolute value of the negative peak of J is above 100 mA/m2 for patient AA, and 
above 20 mA/m2 for patient BB and CC.
Robustness of the semi-specific model with respect to changes in the anatomy of the head have been proven 
by simulating the ischemic volume inside two other generic head models: the Glenn model34,35 (ViP, cV3.1, 
84-year-old man) and the MIDA model36 (28-year-old woman). For each model, the peak of the histogram that 
shows frequency of occurrence of B field intensities inside the ischemic volume was 2.01 mT and 1.95 mT, respec-
tively, leading to a 5% maximum variation over the value computed with the Duke model (i.e. 2.05 mT), as shown 
in Supplementary Fig. S2.
To better understand what the exposure level meant in terms of a possible reduction or containment of the 
growth of the ischemic volume, we superimposed the 3D model of the one month post-treatment ischemia to 
the pre-treatment one, as shown in Fig. 1 (cyan colored). We conducted an analysis comparing slices of the two 
volumes in the coil-based coordinate system (see Methods). As a representative example, results for patient AA 
are shown in Fig. 3 on planes parallel to the coil (d-plane, Methods). In this figure, the contours of pre- and 
post-treatment slices of ischemia are shown colored in light green and cyan respectively, at three different dis-
tances d from the coil. For each distance, left-side figures represent the slices inside the brain, for immediate 
inspection of the two contours. Distribution of ||B|| is shown in the right-side figures. From Fig. 3 one can observe 
higher post-treatment regions reductions with respect to pre-treatment ones with increasing intensity of B field. 
Similar analysis was conducted considering the distribution of ||J|| intensities. Results for patient AA on d-plane 
and f-plane are shown in Supplementary Figs. S3 and S4.
The data represented in Fig. 3 allows us to hypothesize that the volume reduction is an increasing function of 
the intensity of the fields experienced within the ischemic volume. In principle, this will permit the identification 
of a dose-response curve under proper conditions. Therefore, the following analysis was conducted in order to 
assess the best approach to attain such a result. Since the lesions are exposed to intensities greater than 1 mT, this 
is taken as the minimum exposure value. At first we chose 4 ranges for the B field and 5 for the J field and we 
quantified the partial volume of ischemia that is within each range, both for the pre-treatment ischemic lesion 
(Vpre) and for the post- one (Vpost). Table 1 reports, for each exposure range, the lesion variations quantified as the 
ratio between Vpost and Vpre. Thus, a value above 1 indicates that the ischemic volume has enlarged, while a value 
below 1 shows that there’s been a reduction of the volume. Looking at the B field for patient AA and patient BB, 
we can see a visible reduction of the ischemic lesion (over 50%) when the exposure level is greater than 1.7 mT. 
However, when it comes to the regions exposed to less than 1.7 mT, data for patient AA show a two fold increase of 
Figure 3. ||B|| field distribution of patient AA on the planes parallel to the coil. Analysis is carried out at 
different distances d from the coil. For each distance, the edges of the slice of ischemia before (pre, in light 
green) and after (post, in cyan) the treatment are given, in order to compare the dimensions.
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the volume after the treatment, a value that is closer to the volume increase typical of untreated lesions. The same 
cannot be said for patient BB or CC, for whom the respective volumes exposed to the range from 1.3 mT to 1.7 mT 
(upper limit excluded) or from 1 mT to 1.3 mT (upper limit excluded) have slightly reduced after the treatment 
(up tp 12%). When considering J, each ischemic volume exposed to intensities above 5 mA/m2 has reduced for all 
the three patients (see Supplementary Table S1).
Such data confirm that it is possible to assess a dose response behavior but, due to intrinsic biological and 
patient variability, all the data needs to be pooled together in order to attain statistical significance. To move for-
ward in this direction, we conducted a similar analysis looking at volumes defined only by lower limit thresholds 
instead of exposure ranges, see Methods for a detailed explanation.
Fig. 4 shows the ratio between post-treatment and pre-treatment volumes as a function of ||B|| thresholds for 
all the three patients. The ratio is expressed as a percentage, so a value equal to 100% allows us to say that no 
reduction was obtained for that specific intensity. Because all the markers are below 100%, we can say that this 
treatment led to an overall reduction of the ischemic volume in the three patients considered. This analysis quan-
titatively confirms what previously inferred; each patient is characterized by different ratios but we can generally 
say that the higher is the intensity of exposure, the most effective is the treatment (i.e. the lower is the percentage 
of the post-treatment volume). Fig. 4 also shows an exponential fitting for data points of all patients pooled 
together; we show that a decaying exponential function well fits the values of this reduction. The function we used 
for the fitting is defined as =f x Me( ) ax, with x = B and M and a respectively equal to 79.38 and −0.1. The same 
analysis was conducted over the current density J, where a decaying exponential trend was found as well (See 
Supplementary Fig. S5).
Discussion and conclusions
In the context of biomedical applications based on electromagnetic stimulation, computational dosimetry is a 
fundamental tool to quantify the induced electromagnetic quantities related to the dose necessary to exert the 
effect. This is extremely important for the optimization of the application and to deepen the underlying mech-
anisms. Particularly, in the framework of stroke studies, some papers investigated how the presence of a lesion 
can alter the distribution of induced electric field and current inside the brain. Wagner and co-workers37 fol-
lowed a stroke in its chronic state to understand the effects that electrical and anatomical changes can have on 
the current induced in the brain after exposure to TMS. To do so, they considered a numerical human healthy 
head model and 11 stroke models of different sizes and geometries. The stroke models were implemented by 
Ranges
Patient AA Patient BB Patient CC
Vpost/Vpre Vpost/Vpre Vpost/Vpre
B (mT)
1 ÷ 1.3 2.33 / 0.93
1.3 ÷ 1.7 2.41 0.88 0.00
1.7 ÷ 2 0.47 0.33 /
≥2 0.14 / /
Table 1. Ratio between post-treatment and pre-treatment ischemic volume regions, selected based on the 
different ranges of exposure they experience. The slash symbol shows that neither pre-treatment nor post-
treatment ischemia is present in that specific region.
Figure 4. Scatter plot of the percentage quantity “ratio” with respect to increasing values of lower bound B field 
thresholds. Data for the three patients are pooled together, resulting in a decaying exponential function. Ratio is 
defined as the percentage of Volumepost/Volumepre, where: Volumepre = Ischemic pre-treatment volume that was 
exposed to B intensity greater than or equal to a certain threshold during the treatment. Volumepost = Ischemic 
post-treatment volume that is present in a region of the brain that was exposed to a B intensity greater than or 
equal to a certain threshold, during the treatment.
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altering the cortical geometry and properties of the healthy head model guided by brain MRIs of patients with 
cortical strokes. They demonstrated that a stroke can drastically affect TMS application, by altering the location 
of the maximum current density and modifying the focus of the stimulation. A similar approach was adopted 
to estimate the electric field distribution inside brain stroke patients receiving tDCS (transcranial direct current 
stimulation)38. Here a generic spherical volume was placed inside the head of the human body models Ella and 
Glenn (Virtual Population - ViP34,35), to simulate an ischemic lesion. Additionally, electromagnetic properties of 
the sphere were varied to take into account both acute and chronic phase of the stroke. Similar to what was found 
for the TMS, results in Manoli et al.38 showed that the presence and type of lesion affected the maximum value 
and the distribution of the field induced in the brain after exposure to tDCS. Moreover, Manoli and co-workers38 
demonstrated that patients in chronic phase benefit more from tDCS than patients in acute phase, given the 
higher contrast in tissue conductivity. The limitation of both these studies is that they don’t consider a realistic 
shape of the stroke, which becomes crucial when the dosimetric analysis is required to support a dose-response 
study on patient specific clinical treatment.
Specifically, in the context of ongoing studies intended to demonstrate whether PEMFs are able to elicit a 
neuroprotective effect on patients with ischemic stroke, the objective of the present paper was to identify a meth-
odology for a dose-response curve assessment suitable to be applied in a large scale clinical study. To this scope, 
we analysed in details the exposure undergone in the study of Capone et al.17. In particular, we aimed to demon-
strate that the type of exposure obtained with a single solenoid placed laterally to the head and co-centered with 
the ischemic lesion is able to induce a magnetic pulse with peak values above 1 mT under proper conditions. This 
intensity has been shown to exert effects on neuronal cells at the molecular level, increasing the density of adeno-
sine receptors A2A and A3A on the cell membrane9,10. To verify the intensity of B field which each patient has been 
exposed to during the treatment, electromagnetic simulations were performed on a patient semi-specific head 
model. Such model was realized using the geometric information of the ischemic area, obtained from the MRI 
data of the patient, that had been then placed inside a standard computational model. Results of the simulations 
showed that the ischemic volumes in the brain experienced a magnetic flux density field always above the desired 
1 mT. Moreover, quantitative post-elaboration studies were performed on the ischemic lesion. Particularly, while 
the analysis of ischemic slices qualitatively suggested us a correlation between ischemic lesion reduction and 
B field values experienced, the volumetric analysis allowed us to assess the percentage of volume associated to 
specific thresholds. In this sense, the fitting curve of Fig. 4 takes into account post- and pre-treatment volumes 
ratio above a certain given lower field threshold, showing that increasing such a value (i.e. excluding volumes 
experiencing lower fields) decreases the ratio, ultimately indicating a better efficiency in eliciting the effect. As an 
example, by looking at Fig. 4 we can say that a 50% reduction of the volume was obtained by exposing to a B field 
of intensity around 1.4 mT, or, similarly, by inducing a current density of about 5 mA/m2 (Supplemetary Fig. S5). 
Fig. 4 can be considered the example on how to attain a dose response curve when a sample of volunteers large 
enough will be used.
In conclusion, we have demonstrated that, by using electromagnetic simulations on virtual body models 
combined with patient specific lesions, it is possible to build a dose–response curve in an “electroceutical” per-
spective19 when dealing with a large number of patients. This is necessary if one, aiming to introduce a new elec-
tromagnetic–based therapy, like the I-NIC, wants to follow an approach similar to the drugs clinical trials, as an 
example one can think to a typical Phase2 study39. Limitations: This methodology was conceived for the ongoing 
I-NIC study18, but here it is applied to the reduced sample of the three patients recruited in Capone et al.17 that 
underwent magnetic stimulation for 120 minutes (the same treatment duration as the one used in the I-NIC 
study18). Thus, such an approach will be a powerful tool to a reliable assessment of a dose-response threshold of 
the treatment when a large number of patients will be evaluated.
Methods
The study complied with the Helsinki declaration and was approved by the local ethics committee (Università 
Campus Bio-Medico di Roma) and Italian Ministry of Health. Informed consent was obtained from all par-
ticipants. The study was registered with ClinicalTrials.gov, number NCT01941147 (September 9, 2013). The 
study protocol has been published40. Numerical dosimetry was performed on the three subjects exposed for 
120 minutes.
To perform the dosimetric analysis, we used the software Sim4Life v.3.4 (ZMT, Zurich MedTech AG), with the 
Magnetic Quasi Static module. The model used to perform the EM simulations has been defined as semi-specific, 
this because the 3D model of the ischemic lesion of each patient that underwent the 120-minutes-treatment was 
entered in a standard human head model, obtained from the Virtual Population member Duke (v.1.0, Zurich 
MedTech AG34). This version of Duke is a 1 mm voxeled male model counting a total number of 77 different 
tissues, of which we have selected only the 40 structures of the head. Electric properties of tissues are built-in in 
Sim4Life v.3.4 and they are based on IT’IS database41. In order to perform the EM simulation, computational 
model of the stimulation device must be considered as well. The concept behind the semi-specific model and the 
final geometry are shown in Fig. 5. A detailed description is reported as follows.
coil model and simulation parameters. The medical device used by IGEA company for both the study 
conducted in Capone et al.17 and in the I-NIC clinical study18 to deliver PEMFs consists in a generator of a pulsed 
current signal that supplies an external coil (solenoid), that, in turn, generates a pulsed electromagnetic field, with 
a duration of the active phase of the signal equal to 1.3 ± 0.1 ms and a repetition frequency of 75 Hz16. The coil 
is a 240-turned solenoid with a rectangular shape and is held in position upon the ischemic hemisphere with a 
helmet, placed on the head of the patient by means of a Velcro strap17. This geometry was reproduced in the simu-
lation environment, where a single turn rectangular coil of 14 × 10.6 cm (mean length of the 240 turns of the sole-
noid), with no thickness, was designed. The peak value of the pulsed current signal that feeds the rectangular coil 
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is 240 A. The solenoid model was validated after comparison between measured and simulated B field distribution 
over the coil plane at the time peak (Fig. 6b,c). After validation, for the three different patient conditions, the coil, 
was properly warped in order to simulate the solenoid properties of being adaptable to the head shape (Fig. 5a).
As it’s not possible to work in time domain when using Sim4Life v.3.4.0, authors followed the same procedure 
described in Paffi et al.22, that has been implemented based on the harmonic decomposition of the pulsed signal 
simulations. This method allows accounting for frequency dependence of both conductivity and permittivity of 
brain tissues in the signal frequency band. Therefore, 150 simulations were conducted in the frequency range 
[50–7500] Hz with a step of 50 Hz. The aforementioned range contains the frequency components necessary to 
appropriately reconstruct the time course of the pulsed current signal, whose Power Spectral Density is reported 
in Fig. 6a. Time course of magnetic flux induction B and current density J induced in the ischemic tissue was 
previously described in Fig. 2 of the Results.
Ischemic volumes: from MR images to 3D model. The 3D model of the ischemic tissue was obtained 
by segmenting the MRI scans of each of the patient that underwent the treatment for 120 minutes. MRI data 
is shown in grey scale, giving the possibility to distinguish different tissues. Particularly, the ischemic lesion is 
clearly visible, among all the other brain structures, as it is strongly hyperintense. The procedure adopted to 
obtain the 3D model of the ischemia has been described in Capone et al.17, and will be briefly summarized here:
 1. Lesion area is segmented with a semi-automatic region growing segmentation tool, followed by a manual 
editing of the edges.
 2. After the segmentation, the voxels belonging to the ischemic volume are marked with a unitary value, 
while all the others are considered equal to zero. In this way, we obtain a binary mask that contains only the 
geometry of the ischemia.
 3. After conversion in a .raw file, each binary mask is imported in Sim4Life v.3.4 and processed in order to 
generate the surface of the ischemia. Since the resolution of these data, especially in the longitudinal axis, is 
lower than the one of the head model, a smoothing function with an iterative algorithm that adapts the two 
different discretizations have to be applied.
This procedure was implemented to obtain, for each patient, two different models of the ischemia: before and 
one month after the treatment. In Fig. 5b, the model of each pre-treatment ischemia is reported in green. The 
model representing the pre-treatment volume was included in the dosimetric study, as it simulates the lesion 
treated with the PEMFs stimulation. Instead, post-treatment ischemia is considered only during post-processing 
to evaluate and quantify variations of the geometry, in terms of area and volume.
Assembly of the model and dosimetric problem solving. Once both the coil and the ischemia models 
are created, they must be conveniently placed with respect to Duke’s head, following the idea described in Fig. 5. 
First of all, it was necessary to put the ischemic volume inside the head model. A first placement was obtained by 
importing MRI slices of the whole head of each patient in Sim4Life and adjusted to those of Duke, in order to find 
landmarks that helped for a first positioning of the ischemia. Final adjustment was obtained by visual inspection 
with physicians. After this, the coil was placed as close as possible to the head, with the ischemic volume centered 
Figure 5. Sketch of workflow, (a) step 1: solenoid model (experimentally validated), (b) step 2: semi-specific 
model based on reconstructed ischemic volume for each patient, (c) step 3: dosimetric evaluations.
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along the coil axis. In this way, we obtained three different configurations corresponding to the three different 
patient conditions, as shown in Fig. 7. Additionally, to evaluate the effect of a possible misplacing of the stimulator 
during the treatment, the coil was shifted by ±1 cm over the head along the longitudinal and transversal direc-
tions in patient AA. Results showed a 2% maximum variation for the peak of the histogram that shows frequency 
of occurrence of B field intensities inside the ischemic lesion (see Supplementary Fig. S6), demonstrating robust-
ness over changes in the position of the coil. As already discussed above, we solved the electromagnetic problem 
considering only the pre treatment ischemia, to which electric properties of the edema42 were assigned, which 
Figure 6. Stimulation model. (a) Pulsed signal in frequency domain; simulated ||B|| (c) and measured ||B|| (d) 
on the plane of the coil. Measurements are conducted with the Gaussmeter/Teslameter Model DG-50, from the 
company Laboratorio Elettrofisico.
Figure 7. Final semi-specific patient models: all patients are shown on xz-plane. The shortest distance between 
the ischemia and the coil is defined as dmin.
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means a conductivity σ equal to 1.7 S/m and the same relative permittivity εr as the grey matter. Head tissues were 
automatically assigned through IT’IS database. To perform the simulation, a 0.5 mm and a 1 mm isotropic reso-
lution were imposed to the ischemia and to Duke’s skin respectively, whereas Sim4Life default resolution of 
0.625 × 0.625 × 0.625 mm was imposed to the remaining structures.
Comparison between pre-treatment and post-treatment volumes. Aiming to obtain a correla-
tion between intensity of the electromagnetic quantities (B and J) and changes in ischemic volume and geom-
etry, a first surface-based analysis was conducted on single slices of the lesion. In this sense, the 3D models of 
pre-treatment and post-treatment ischemia were cut in slices along specific directions, with a relative distance 
between two consecutive slices equal to 5 mm. In order to conduct this study, we chose to work with a coil-based 
frame of reference, instead of the default cartesian coordinate system X-Y-Z. The new system consists of three 
orthogonal axis, defined as d, f and t, where d is the normal to the d-plane, which is parallel to the coil, as it passes 
through its four vertices. While axes t and f are defined as the vectors normal to the t-plane and the f-plane, 
respectively. These two planes are orthogonal to the coil, because they pass through two of its four vertices, i.e. 
chosen as those belonging to the short or the long side of the coil, respectively. The three planes described above 
are shown in Fig. 8a, where it is also shown that each plane is shifted along its normal, in order to obtain the slic-
ing of both pre-treatment (green) and post-treatment (cyan) lesion. With this procedure, we did a first evaluation 
of pre- and post-treatment regions, as extensively described in the results. However, this surface-based analysis is 
limited by the finite dimensions of the ischemia, which could cause a misreading of data for those slices bordering 
with the extremities of the object. For this reason, rather than performing a quantitative evaluation with this pro-
cedure, we decided to focus on volumetric considerations. We applied the same concept when considering both 
the magnetic flux density field, B, and the induced current density, J. Either way, we selected as thresholds specific 
intensities within the range of all the values experienced by the ischemic volume. The amount of pre-treatment 
volume exposed to a field equal or greater than the selected threshold was computed. In order to apply this evalu-
ation to the post-treatment ischemia, we identified exposure levels on brain regions where the ischemic volume is 
present one month after the treatment. Thus, considering the same thresholds, we could compute the amount of 
post-treatment ischemic volume that lies on regions previously exposed to the given field values. The purpose of 
this analysis was to assess how much post-treatment volume persisted in a region treated with intensities at least 
equal to the chosen threshold. In Fig. 8b we visually describe how this procedure works when considering the 
B field: as already mentioned in the Results, B is homogeneously distributed along the d-plane and its intensity 
depends only on the distance from the coil. For this reason, post- and pre-treatment ischemic volume exposed 
to a magnetic field equal or greater than the set threshold will be approximately all above the plane parallel to the 
coil, placed at a specific distance d from it. However, this simplified representation is only possible when consid-
ering the B field, while the distribution of J is strongly influenced by the encountered tissues.
Data availability
Data generated and/or analyzed during the current study are available from the corresponding author on 
reasonable request.
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Figure 8. (a) Planes relative to the coil used to observe pre-treatment and post-treatment ischemic slices. (b) 
Example of volume selection: here the threshold is set for B to 1.7 mT. Inside the blue smaller circle: the volume 
of ischemia exposed to a B field equal or greater than 1.7 mT is represented in white; how that partial volume 
has changed after the treatment is shown in cyan.
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